Completed

WebQuit PlusWeb-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder

What is being tested

Experimental plus Nicotine Replacement Therapy

+ Control plus Nicotine Replacement Therapy

Behavioral

Who is being recruted

Bipolar and Related Disorders+5

+ Behavior

+ Mental Disorders

Over 18 Years

+23 Eligibility Criteria

See all eligibility criteria

How is the trial designed

Treatment Study

Interventional

Study Start: April 2017

See protocol details

Summary

Principal SponsorFred Hutchinson Cancer Center

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: April 3, 2017

Actual date on which the first participant was enrolled.

The study consist of two separate phases. Phase I consists of website usability testing. Investigators will collect feedback and incorporate the feedback into our website that is tailored for people with bipolar disorder. In Phase II investigators will be comparing quit rates of two groups both utilizing Nicotine Replacement Therapy and a website.

Official TitleWeb-Delivered Acceptance & Commitment Therapy for Smokers With Bipolar Disorder

NCT02750904

Principal SponsorFred Hutchinson Cancer Center

Last updated: January 28, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

51 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Bipolar and Related DisordersBehaviorMental DisordersBipolar DisorderSmokingHealth BehaviorSmoking CessationMood Disorders

Criteria

10 inclusion criteria required to participate

Age 18 or older

Daily smoker for the past year, averaging at least 5 cigarettes per day for the past 30 days, with expired-air carbon monoxide (CO) level ≥ 4 ppm

Motivated to quit smoking (i.e., endorse plans to quit in the next 30 days at the time of phone pre-screening)

Meets lifetime criteria for bipolar I or II disorder, based on DSM-V criteria

Show More Criteria

13 exclusion criteria prevent from participating

Participating in other smoking cessation interventions

Currently using any pharmacotherapies for smoking cessation

Previous use of the Smokefree.gov website

Meets DSM-V criteria for current mania

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Treatment Groups

Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group

Treatment Groups

Group I

Experimental

Group II

Active Comparator

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 4 locations

Suspended

Palo Alto Veterans Institute for Research

Palo Alto, United StatesOpen Palo Alto Veterans Institute for Research in Google Maps

Suspended

Jefferson Center for Mental Health

Denver, United States

Suspended

Bedford VA Research Corp

Bedford, United States

Suspended

VA Central Western Massachusetts Healthcare System

Leeds, United States

Completed4 Study Centers